
Aureka Biotechnologies is a biotech startup focused on transforming pharmaceutical discovery through a digital biology and AI platform. Their technology enables rapid, efficient discovery of high-value protein therapeutics, targeting previously difficult mechanisms and reducing time and cost. The company operates a best-in-class platform ecosystem for immunotherapeutic discovery, partnering with pharma and biotech firms to design novel antibody therapeutics. Their interdisciplinary team combines expertise in synthetic biology, single-cell technologies, data science, computational biology, and deep learning to innovate continuously in therapeutic discovery.

Aureka Biotechnologies is a biotech startup focused on transforming pharmaceutical discovery through a digital biology and AI platform. Their technology enables rapid, efficient discovery of high-value protein therapeutics, targeting previously difficult mechanisms and reducing time and cost. The company operates a best-in-class platform ecosystem for immunotherapeutic discovery, partnering with pharma and biotech firms to design novel antibody therapeutics. Their interdisciplinary team combines expertise in synthetic biology, single-cell technologies, data science, computational biology, and deep learning to innovate continuously in therapeutic discovery.
Founded: 2023
Headquarters: Laguna Hills, California
Focus: Digital biology and AI platform for protein and immunotherapeutic discovery
Notable tech: High-throughput single-cell screening, synthetic biology, generative AI
Reported funding: $10M seed (reported); total funding records list $33,370,000
| Company |
|---|
Drug discovery for protein- and antibody-based therapeutics, including immunotherapies and complex multi-objective design challenges.
2023
Biotechnology
$10,000,000
Dealroom and Crunchbase entries report a $10M seed; investor listings show K2VC and NRL Capital as lead investors.
“5Y Capital; BioTools Innovator; K2VC; NRL Capital; Newlife Capital; Qiming Venture Partners”
About the job
Location: Irvine, CA
Company Summary:
Aureka Biotechnologies is an AI-driven biotech startup integrating high-throughput biology with generative AI to discover and develop antibody therapeutics with exceptional speed and precision. Through multiple pharma collaborations, our platform has been validated to deliver best-in-class, differentiated antibodies that are difficult to identify using traditional discovery methods.
Position Summary:
Aureka Bio is seeking a highly motivated and detail-oriented Associate Scientist or Scientist to join our Assay Development Team. This position offers the opportunity to contribute to a dynamic, AI-enabled biotherapeutics company dedicated to rapidly generating next-generation biologics in Immunology & Inflammation (I&I), metabolic, and fibrotic diseases.
The successful candidate will design, develop, and execute biochemical, cell-based, and in vivo translational assays to characterize antibody function, signaling, and efficacy. This individual will work closely with the protein engineering, molecular biology, and in vivo pharmacology teams to provide critical functional and mechanistic insights that drive Aureka’s antibody discovery programs.
This is a bench-facing, on-site position based in Irvine, CA, offering high visibility and the opportunity to directly influence therapeutic discovery programs. The final title and level will be determined based on experience.
Key Responsibilities
Professional Experience and Qualifications
Preferred:
Compensation:
Competitive and commensurate with experience, including salary, equity, and benefits—aligned with the company’s long-term success.
Why join us: